Acute Coronary Stent Thrombosis in Modern Era: Etiology, Treatment, and Prognosis

被引:16
作者
Ge, Junhua [1 ]
Yu, Haichu [1 ]
Li, Jian [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Cardiol, Jiangsu Rd 16, Qingdao 266000, Shandong, Peoples R China
关键词
Stent thrombosis; acute; Percutaneous coronary intervention; Coronary artery; DRUG-ELUTING STENT; OPTICAL COHERENCE TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; BIORESORBABLE VASCULAR SCAFFOLDS; RANDOMIZED CONTROLLED-TRIALS; HIGH BLEEDING RISK; BARE-METAL STENTS; ARTERY-DISEASE; PLATELET REACTIVITY; CARDIOVASCULAR EVENTS;
D O I
10.1159/000464404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute stent thrombosis (AST) is a rare but life-threatening complication of coronary artery stenting. AST remains a challenging task for cardiologists, despite the application of modern procedural techniques and dual-antiplatelet therapy strategies as well as improved understanding of the underlying pathophysiology. This review focuses on the prevalence, risk factors, prognosis, multiple potential underlying pathogenesis, knowledge gaps, and recommends diagnosis and individualized management strategies of AST. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:246 / 255
页数:10
相关论文
共 57 条
  • [1] Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding?
    Aradi, Daniel
    Collet, Jean-Philippe
    Mair, Johannes
    Plebani, Mario
    Merkely, Bela
    Jaffe, Allan S.
    Moeckel, Martin
    Giannitsis, Evangelos
    Thygesen, Kristian
    ten Berg, Jurrien M.
    Mueller, Christian
    Storey, Robert F.
    Lindah, Bertil
    Huber, Kurt
    [J]. THROMBOSIS AND HAEMOSTASIS, 2015, 113 (02) : 221 - 230
  • [2] Clinical Presentation, Management, and Outcomes of Angiographically Documented Early, Late, and Very Late Stent Thrombosis
    Armstrong, Ehrin J.
    Feldman, Dmitriy N.
    Wang, Tracy Y.
    Kaltenbach, Lisa A.
    Yeo, Khung-Keong
    Wong, S. Chiu
    Spertus, John
    Shaw, Richard E.
    Minutello, Robert M.
    Moussa, Issam
    Ho, Kalon K. L.
    Rogers, Jason H.
    Shunk, Kendrick A.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (02) : 131 - 140
  • [3] Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study)
    Biscaglia, Simone
    Ugo, Fabrizio
    Ielasi, Alfonso
    Secco, Gioel Gabrio
    Durante, Alessandro
    D'Ascenzo, Fabrizio
    Cerrato, Enrico
    Balghith, Mohammed
    Pasquetto, Giampaolo
    Penzo, Carlo
    Fineschi, Massimo
    Bonechi, Francesco
    Templin, Christian
    Menozzi, Mila
    Aquilina, Matteo
    Rognoni, Andrea
    Capasso, Piera
    Di Mario, Carlo
    Brugaletta, Salvatore
    Campo, Gianluca
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 208 : 40 - 45
  • [4] Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
    Bonaa, K. H.
    Mannsverk, J.
    Wiseth, R.
    Aaberge, L.
    Myreng, Y.
    Nygard, O.
    Nilsen, D. W.
    Klow, N. -E.
    Uchto, M.
    Trovik, T.
    Bendz, B.
    Stavnes, S.
    Bjornerheim, R.
    Larsen, A. -I.
    Slette, M.
    Steigen, T.
    Jakobsen, O. J.
    Bleie, O.
    Fossum, E.
    Hanssen, T. A.
    Dahl-Eriksen, O.
    Njolstad, I.
    Rasmussen, K.
    Wilsgaard, T.
    Nordrehaug, J. E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (13) : 1242 - 1252
  • [5] Intra-Procedural Stent Thrombosis A New Risk Factor for Adverse Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes
    Brener, Sorin J.
    Cristea, Ecaterina
    Kirtane, Ajay J.
    McEntegart, Margaret B.
    Xu, Ke
    Mehran, Roxana
    Stone, Gregg W.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (01) : 36 - 43
  • [6] Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison The BVS-EXAMINATION Study (Bioresorbable Vascular Scaffold-A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction)
    Brugaletta, Salvatore
    Gori, Tommaso
    Low, Adrian F.
    Tousek, Petr
    Pinar, Eduardo
    Gomez-Lara, Josep
    Scalone, Giancarla
    Schulz, Eberhard
    Chan, Mark Y.
    Kocka, Viktor
    Hurtado, Jose
    Gomez-Hospital, Juan Antoni
    Muenzel, Thomas
    Lee, Chi-Hang
    Cequier, Angel
    Valdes, Mariano
    Widimsky, Petr
    Serruys, Patrick W.
    Sabate, Manel
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (01) : 189 - 197
  • [7] Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014
    Byrne, Robert A.
    Joner, Michael
    Kastrati, Adnan
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (47) : 3320 - +
  • [8] Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials
    Cassese, Salvatore
    Byrne, Robert A.
    Ndrepepa, Gjin
    Kufner, Sebastian
    Wiebe, Jens
    Repp, Janika
    Schunkert, Heribert
    Fusaro, Massimiliano
    Kimura, Takeshi
    Kastrati, Adnan
    [J]. LANCET, 2016, 387 (10018) : 537 - 544
  • [9] Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
    Cayla, Guillaume
    Hulot, Jean-Sebastien
    O'Connor, Stephen A.
    Pathak, Atul
    Scott, Stuart A.
    Gruel, Yves
    Silvain, Johanne
    Vignalou, Jean-Baptiste
    Huerre, Yves
    de la Briolle, Axel
    Allanic, Frederick
    Beygui, Farzin
    Barthelemy, Olivier
    Montalescot, Gilles
    Collet, Jean-Philippe
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (16): : 1765 - 1774
  • [10] Stent Thrombosis A Clinical Perspective
    Claessen, Bimmer E.
    Henriques, Jose P. S.
    Jaffer, Farouc A.
    Mehran, Roxana
    Piek, Jan J.
    Dangas, George D.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (10) : 1081 - 1081